Stocks and Investing Stocks and Investing
Wed, March 27, 2024

Carter Gould Maintained (ABBV) at Buy with Increased Target to $195 on, Mar 27th, 2024


Published on 2024-10-28 09:56:55 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $185 to $195 on, Mar 27th, 2024.

Carter has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Rajesh Kumar of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $156 on, Monday, December 18th, 2023


These are the ratings of the 7 analyists that currently disagree with Carter


  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, February 6th, 2024
  • Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $189 on, Tuesday, February 6th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, February 5th, 2024
  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $195 on, Monday, February 5th, 2024
  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024
  • Chris Shibutani of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $173 on, Monday, December 11th, 2023

Contributing Sources